| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 11029164 | Epilepsy & Behavior | 2018 | 10 Pages |
Abstract
Administration of a therapeutic dose of CBD (750â¯mg) showed significantly low abuse potential in a highly sensitive population of polydrug users. Although high and supratherapeutic doses of CBD (1500â¯mg and 4500â¯mg, respectively) had detectable subjective effects compared with placebo; the effects were significantly lower than those observed with alprazolam and dronabinol.
Related Topics
Life Sciences
Neuroscience
Behavioral Neuroscience
Authors
Kerri A. Schoedel, Isabella Szeto, Beatrice Setnik, Edward M. Sellers, Naama Levy-Cooperman, Catherine Mills, Tilden Etges, Kenneth Sommerville,